e-learning
resources
Stockholm 2002
Sunday 15.09.2002
Asthma: Inflammation, hyperreactivity, treatment side effects
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Influence of inhaled corticosteroids on intraocular pressure in patients with asthma and glaucoma
M. Konareva-Kostianeva, S. Kostianev, P. Strumeliev (Plovdiv, Bulgaria)
Source:
Annual Congress 2002 - Asthma: Inflammation, hyperreactivity, treatment side effects
Session:
Asthma: Inflammation, hyperreactivity, treatment side effects
Session type:
Thematic Poster Session
Number:
433
Disease area:
Airway diseases
Abstract
The aim of this study was to investigate the influence of inhaled corticosteroids (ICS) on intraocular pressure (IOP) in asthmatics with primary open angle glaucoma with and without family history of glaucoma. Three hundred and five glaucomatous patients with visual field defects, optic disc changes and elevated IOP and 145 control subjects participated in the study. Twenty asthmatics treated with ICS were found to form three groups: I group - 4 asthmatics with glaucoma that have family history of glaucoma, II group - 9 asthmatics with glaucoma without family history of glaucoma and III group - 7 asthmatics without glaucoma. The asthmatic patients with glaucoma and family history have higher IOP than those with glaucoma without family history - IOP mmHg = 26.6±]2.7 vs. 23.2±]3.6 (p<0.05) and showed more severe visual field defects - Mean Deviation 7.6±]4.1 vs 2.7±]2.8 (p<0.05). IOP was normal (16.0±]3.1 mm Hg) in all asthmatics without glaucoma except one subject who showed an ocular hypertensive response to ICS. The results support the hypothesis that the patients with family glaucoma inherit not only glaucoma disease but also increased susceptibility to corticosteroids. In conclusion, glaucomatous asthmatics on ICS, exspecially those with family history of glaucoma, need special care and follow-up by ophthalmologist.
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
M. Konareva-Kostianeva, S. Kostianev, P. Strumeliev (Plovdiv, Bulgaria). Influence of inhaled corticosteroids on intraocular pressure in patients with asthma and glaucoma. Eur Respir J 2002; 20: Suppl. 38, 433
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Management of Severe Asthma in Pediatric Patients by an Interdisciplinary Team in a Public Hospital Setting.
Impact of Dexamethasone on pathogen profile of COVID-19 patients requiring intensive care: a multicentre retrospective study
Related content which might interest you:
The effect of inhaled fluticason propionate on intraocular pressure of patients with bronchial asthma
Source: Eur Respir J 2006; 28: Suppl. 50, 500s
Year: 2006
Low-dose inhaled and nasal corticosteroid use and the risk of cataracts
Source: Eur Respir J 2006; 27: 1168-1174
Year: 2006
Intraocular pressure and occurrence of cataracts in children treated for a mean of 16 years with inhaled budesonide
Source: Annual Congress 2010 - Paediatric asthma treatment and monitoring
Year: 2010
Effects of inhaled corticosteroids on cough in asthma patients
Source: Eur Respir J 2004; 24: Suppl. 48, 347s
Year: 2004
Intraocular pressure in glaucoma patients varied considerably after nasal CPAP compared to control subjects
Source: Annual Congress 2003 - Management of sleep related breathing disorders
Year: 2003
Step-up therapy for children with uncontrolled asthma receiving inhaled corticosteroids
Source: Breathe 2010; 6: 365
Year: 2010
Evaluation of ocular complications of long-term inhaled steroid use
Source: Eur Respir J 2001; 18: Suppl. 33, 97s
Year: 2001
Ipratropium bromide effects on intraocular pressure in COPD patients
Source: Eur Respir J 2005; 26: Suppl. 49, 287s
Year: 2005
Effect of add-on montelukast to inhaled corticosteroids on excessive airway narrowing in adult asthmatics
Source: Annual Congress 2009 - Aspects of clinical asthma
Year: 2009
Effect of inhaled bronchodilators on the neurovegetative status of patients with bronchial asthma
Source: Annual Congress 2008 - Clinical aspects of asthma in school-aged children
Year: 2008
CPAP related intraocular pressure increase at night in people with and without glaucoma.
Source: International Congress 2018 – Sleep-disordered breathing: cardiovascular consequences, epidemiology, phenotypes and comorbidities
Year: 2018
Effects of intervention with high-dose inhaled corticosteroids on airway remodelling in diagnosed genetic variants of
IL13
with asthma
Source: Annual Congress 2010 - Asthma: clinical aspects and treatment
Year: 2010
Impact of inhaled corticosteroids in patients with cardiovascular disease
Source: Eur Respir Monogr 2020; 88: 251-263
Year: 2020
Long-term adherence to inhaled corticosteroids and asthma control in adult-onset asthma
Source: Virtual Congress 2020 – Inhaled corticosteroids and bronchodilator studies in asthma
Year: 2020
Effect of nasal topical steroids on CPAP compliance in patients with obstructive sleep apnoea starting therapy
Source: Annual Congress 2007 - Treatment options in obstructive sleep apnoea
Year: 2007
Effectiveness of nebulizing heliox coupled to bronchodilators and body positioning in severe asthma patients
Source: Annual Congress 2009 - Treatment modalities in chest physiotherapy
Year: 2009
Nebulizer therapy with budesonide in addition to systemic corticosteroids in acute severe asthma
Source: Eur Respir J 2004; 24: Suppl. 48, 541s
Year: 2004
Efficacy of systemic corticosteroids in refractory asthmatics showing no bronchial reversibility with high-dose inhaled corticosteroids or β
2
agonist inhalation
Source: Annual Congress 2010 - Clinical aspects and treatment of asthma and allergic respiratory diseases
Year: 2010
Effects of montelukast on tapering inhaled corticosteroids in patients with asthma
Source: Eur Respir J 2001; 18: Suppl. 33, 260s
Year: 2001
Effects of montelukast on tapering inhaled corticosteroids in patients with asthma
Source: Eur Respir J 2002; 20: Suppl. 38, 407s
Year: 2002
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept